Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia
- 22 March 2007
- journal article
- Published by Springer Nature in Leukemia
- Vol. 21 (5) , 1116-1122
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Polycomb silencers control cell fate, development and cancerNature Reviews Cancer, 2006
- Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosisBlood, 2006
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid LeukemiaInternational Journal of Hematology, 2005
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Bmi-1 determines the proliferative capacity of normal and leukaemic stem cellsNature, 2003
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Partial Tandem Duplications of the MLL Gene Are Detectable in Peripheral Blood and Bone Marrow of Nearly All Healthy DonorsBlood, 1998